At the IGTP TODAY
The Innomed program, an initiative led and coordinated by the IGTP, has concluded the second edition of its GrowInn project incubator with the celebration of the Innomed Awards, which have gathered over 150 people and recognised five projects for their talent and determination.
_1750336882.jpeg)
The first CORE IGTP Scientific Conference was held at the Badalona International Business Centre (BCIN), an initiative of the CORE Program that aims to establish itself as an annual space for meeting, debate and scientific exchange among professionals involved in population health research.
Researchers from ICREC-IGTP have conducted a preclinical study on the effects of the drug empagliflozin, alone or in combination with sacubitril/valsartan, in the early phase following a myocardial infarction. The combination of the two showed promising results.
Researchers from the Experimental Tuberculosis Unit (UTE) at the IGTP and the Germans Trias i Pujol University Hospital have published a study in Nature Communications in which, for the first time, the transcriptomic profile of human tuberculosis lung lesions is correlated with clinical data from the same patients.
The IGTP, through the INEDIT group, is involved in three major European projects committed to health innovation, with over €12 million in funding.
_1749029861.JPG)
On 2 June, IGTP hosted the kick-off event for the DM1-Hub, a multicentre project driven by the the group GRENBA, which aims to create a comprehensive national registry of patients with Myotonic Dystrophy type 1 (DM1). The event brought together researchers, clinical professionals, institutional representatives and patient associations from across Spain.
The episode features Eva Martínez-Cáceres and Cristina Ramo. Together, they explain the basics of multiple sclerosis and the research they are conducting. The episode also includes the testimony of a patient, who shares what it is like to live with the disease.
The study presents a new mouse model that more realistically mimics the disease caused by SARS-CoV-2 in humans, an essential tool for better understanding COVID.
The podcast of IGTP launches its ninth episode to mark World Malaria Day. This infectious disease, although under control in some regions, still affects more than 200 million people worldwide.
This March, IGTP resumed the round of visits from La Marató de TV3 donors to its laboratories, as part of the Visita la recerca program, offering a closer look at the progress of funded research projects.
_1742909618.png)